Data for: The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression: A Bayesian Meta-analysis

Annelieke Roest (Contributor)
Rei Tendeiro-Monden (Contributor)
Peter de Jonge (Contributor)
Richard Morey (Cardiff University) (Contributor)
Eric-Jan Wagenmakers (Contributor)
Klaas Wardenaar (Contributor)
Don van Ravenzwaaij (Contributor)

Dataset

Description

The data extracted from the FDA review.

Date made available	26-Apr-2018
Publisher	University of Groningen

Keywords on Datasets

Antidepressants
Depression

Contact

researchdata@rug.nl

DOI
10.17632/p3k5h38xpn.1

Access Dataset

https://data.mendeley.com/datasets/p3k5h38xpn

1 Article

The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression in the US: A Bayesian meta-analysis of Food and Drug Administration reviews
Monden, R., Roest, A. M., van Ravenzwaaij, D., Wagenmakers, E-J., Morey, R., Wardenaar, K. J. & de Jonge, P., 1-Aug-2018, In: Journal of Affective Disorders. 235, p. 393-398 6 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

13 Citations (Scopus)

36 Downloads (Pure)

Cite this

Roest, A. M. (Contributor), Monden, R. (Contributor), de Jonge, P. (Contributor), Morey, R. (Contributor), Wagenmakers, E. (Contributor), Wardenaar, K. J. (Contributor), van Ravenzwaaij, D. (Contributor) (26-Apr-2018). Data for: The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression: A Bayesian Meta-analysis. University of Groningen. 10.17632/p3k5h38xpn.1